On Sept. 5, the FDA announced an import alert and green list for glucagon-like peptide-1 (GLP-1) active pharmaceutical ingredient (API) manufacturers. The FDA included manufacturers on the green list ...
India revised the policy condition governing import of Sulphadiazine active pharmaceutical ingredient (API) recently by imposing a minimum import price (MIP). The import of Sulphadiazine API having a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results